Reuters logo
BRIEF-Global Blood Therapeutics announces enrollment of first patient in phase 3 HOPE study in sickle cell disease
January 18, 2017 / 1:47 PM / 8 months ago

BRIEF-Global Blood Therapeutics announces enrollment of first patient in phase 3 HOPE study in sickle cell disease

Jan 18 (Reuters) - Global Blood Therapeutics Inc :

* Global blood therapeutics announces enrollment of first patient in phase 3 hope study in sickle cell disease Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below